These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5707364)

  • 1. [Changes in the electroencephalogram and neuro-psychic disorders in patients with pulmonary tuberculosis during treatment with cycloserine].
    Chelnokova NV
    Antibiotiki; 1968 Oct; 13(10):918-25. PubMed ID: 5707364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the bioelectric activity of the brain in patients with pulmonary tuberculosis during intolerance cycloserine].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1970 Dec; 15(12):1120-5. PubMed ID: 5501372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of basic tuberculostatic preparations of the 1st and 2d order in the bioelectric activity of the brain in patients with pulmonary tuberculosis].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1969 Sep; 14(9):853-8. PubMed ID: 5361831
    [No Abstract]   [Full Text] [Related]  

  • 4. [Collateral toxic effects of antitubercular drugs: acute psychopathies caused by cycloserine. (Case reports)].
    Zanotelli F; Ghidini O; Bertoni L
    G Clin Med; 1967 Sep; 48(9):972-84. PubMed ID: 5609866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Terisidon in chemotherapy of pulmonary tuberculosis].
    Kolosovskaia VP; Korotaev GA
    Probl Tuberk; 1974; (12):15-8. PubMed ID: 4445129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
    Shmelev NA; Shabalova LN; Kolosovskaia VP
    Antibiotiki; 1975 Feb; 20(2):174-80. PubMed ID: 1091207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.
    Bucco T; Meligrana G; De Luca V
    Scand J Respir Dis Suppl; 1970; 71():259-65. PubMed ID: 5271998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V; Mijatović M; Mirković S; Muzikravić T
    Plucne Bolesti Tuberk; 1972; 24(2):89-98. PubMed ID: 4565191
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapy of pulmonary tuberculosis in psychopathic patients, using terizidone].
    Micheletti V; Teti V; Fenzi P; Usberti G
    Minerva Med; 1968 May; 59(42):2459-65. PubMed ID: 5653337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 12. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary experiences with treatment of pulmonary tuberculosis with 1',4'-bis-D-(3-oxo-4-isoxazolidinyliminomethyl)-benzene (Terizidone)].
    Scarponi F; Dorigoni A
    Arch Maragliano Patol Clin; 1968; 24(4):457-70. PubMed ID: 5755799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of cycloserine on the human body].
    Rózewska M; Gajewska E; Graczyk J
    Gruzlica; 1969 Jun; 37(6):523-8. PubMed ID: 5350917
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs.
    Bethlem N
    Scand J Respir Dis Suppl; 1970; 71():244-9. PubMed ID: 5271994
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
    Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.